What it sells
Automated biotech lab in the Amazon.
Business model breakdown
Buyer: who owns the budget?
UnverifiedLab heads and procurement at Brazilian universities, research institutes, diagnostics and biotech/agro companies.
Trigger: what makes them buy now?
Need protein, gene and reagent supply in Brazil faster than import channels; scale-up to purity for regulators.
Workflow: what inputs become what output?
Order cell-free protein synthesis on demand, gene synthesis, ready kits (PCR, RT-PCR), viral antigens and growth factors; or contract protein discovery and bioprocess optimization.
Economics: what it saves and how it charges
Product sales of reagents/kits and fee-for-service synthesis and development projects.
Distribution: how it reaches customers
UnverifiedWebsite catalog and contact for quotes; partners/clients page.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-06 | — | R$8.4M | — | news.google.com |
| 2026-10-06 | — | $1.7M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.